Molecules 2013, 18(8), 9670-9683; doi:10.3390/molecules18089670
Review

The Emerging Role of Ferumoxytol-Enhanced MRI in the Management of Cerebrovascular Lesions

1 Department of Neurosurgery, Thomas Jefferson University and Jefferson Hospital for Neuroscience, Philadelphia, PA 19107, USA 2 Department of Neurosurgery, University of Iowa, Iowa City, IA 52242, USA
* Author to whom correspondence should be addressed.
Received: 14 June 2013; Accepted: 8 August 2013 / Published: 13 August 2013
(This article belongs to the Special Issue Contrast Agents)
PDF Full-text Download PDF Full-Text [410 KB, uploaded 13 August 2013 11:56 CEST]
Abstract: Inflammation is increasingly being understood to be a key component to the pathophysiology of cerebrovascular lesions. Ferumoxytol, an iron oxide nanoparticle coated by a carbohydrate shell, has been used in MRI studies as an inflammatory marker because it is cleared by macrophages. Ferumoxytol-enhanced MRI has emerged as an important tool for noninvasive assessment of the inflammatory status of cerebrovascular lesions, namely aneurysms and arteriovenous malformations. Moreover, preliminary evidence suggests that ferumoxytol-enhanced MRI could be applied as a non-invasive tool to differentiate “unstable” lesions that require early intervention from “stable” lesions in which observation may be safe. Assessment of the effects of anti-inflammatory pharmacological interventions on cerebrovascular lesions is also a potentially crucial application of the technique. Future improvements in technique and MRI signal quantification will certainly pave the way for widespread and efficient use of ferumoxytol-enhanced MRI in clinical practice. In this paper, we review current data regarding ferumoxytol-enhanced MRI and discuss its current/potential applications and future perspectives.
Keywords: aneurysm; ferumoxytol; arteriovenous malformation; magnetic resonance imaging; inflammation

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Chalouhi, N.; Jabbour, P.; Magnotta, V.; Hasan, D. The Emerging Role of Ferumoxytol-Enhanced MRI in the Management of Cerebrovascular Lesions. Molecules 2013, 18, 9670-9683.

AMA Style

Chalouhi N, Jabbour P, Magnotta V, Hasan D. The Emerging Role of Ferumoxytol-Enhanced MRI in the Management of Cerebrovascular Lesions. Molecules. 2013; 18(8):9670-9683.

Chicago/Turabian Style

Chalouhi, Nohra; Jabbour, Pascal; Magnotta, Vincent; Hasan, David. 2013. "The Emerging Role of Ferumoxytol-Enhanced MRI in the Management of Cerebrovascular Lesions." Molecules 18, no. 8: 9670-9683.

Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert